Stay updated with breaking news from Jamesr Kasinger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price was down 2.7% during trading on Thursday . The company traded as low as $55.34 and last traded at $55.43. Approximately 309,479 shares traded hands during trading, a decline of 82% from the average daily volume of 1,748,323 shares. The stock had previously closed at […]
Capital Investment Advisory Services LLC lifted its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 2.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,636 shares of the company’s stock after buying an additional 855 shares during […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 0.2% during mid-day trading on Monday . The stock traded as low as $54.37 and last traded at $54.95. Approximately 262,647 shares traded hands during trading, a decline of 86% from the average daily volume of 1,824,210 shares. The stock had previously closed at […]
SFE Investment Counsel purchased a new stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 4,900 shares of the company’s stock, valued at approximately $307,000. Other large investors have also recently modified their holdings of […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s share price shot up 2.8% during trading on Thursday after Citigroup raised their price target on the stock from $88.00 to $89.00. Citigroup currently has a buy rating on the stock. CRISPR Therapeutics traded as high as $57.19 and last traded at $57.11. 273,490 shares were traded […]